p53 and p16/CDKN2 gene mutations in esophageal tumors from a high- incidence area in South Africa

International Journal of Cancer

Volumn 78, Issue 5, 1998, Pages 544-549

  Gamieldien, Wedaad ^a   Victor, Thomas C ^a,b   Mugwanya, David ^c   Stepien, Andrew ^c   Gelderblom, Wentzel C A ^a   Marasas, Walter F O ^a   Geiger, Dieter H ^d   Van Helden, Paul D ^b  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c UNIVERSITY OF TRANSKEI   (South Africa)

^d STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; DNA SEQUENCE; ESOPHAGUS CANCER; ESOPHAGUS CARCINOMA; ESOPHAGUS TUMOR; FEMALE; GENE DELETION; GENE MUTATION; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; SOUTH AFRICA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; GENE DELETION; GENES, P16; GENES, P53; HUMANS; MALE; MIDDLE AGED; MUTATION;

EID: 0031792367     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19981123)78:5<544::AID-IJC3>3.0.CO;2-T     Document Type: Article

References (21)

1. AUDRÉZET, M.P., ROBASKIEWICZ, M., MERCIER, B., NOUSBAUM, J.B., BAIL, J.P., HARDY, E., VOLANT, A., LOZAC'H, P., CHARLES, J.F., GOUÉROU, H. and FÉREC, C., TP53 gene mutation profile in esophageal squamous cell carcinomas. Cancer Res., 53, 5745-5749 (1993).
2. CASSON, A.G., MUKHOPADHYAY, T., CLEARY, K.R., RO, J.Y., LEVIN, B. and ROTH, J., p53 gene mutations in Barrett's epithelium and esophageal cancer. Cancer Res., 51, 4495-4499 (1991).
3. COGGI, G. and 12 OTHERS, p53 protein accumulation and p53 gene mutation in esophageal carcinoma. Cancer, 79, 425-432 (1997).
4. GREENBLATT, M.S., BENNETT, W.P., HOLLSTEIN, M. and HARRIS, C.C., Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878 (1994).
5. HARTWELL, L., Defects in cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell, 71, 543-546 (1992).
6. IMAZEKI, F., OMATA, M., NOSE, H., OHTO, M. and ISONO, K., p53 gene mutations in gastric and esophageal cancers. Gastroenterology, 103, 892-896 (1992).
7. JASKIEWICZ, K., MARASAS. W.F.O., LAZARUS, C., BEYERS, A.D. and VAN HELDEN, P.D., Association of esophageal cytological abnormalities with vitamin and lipotrope deficiencies in populations at risk for esophageal cancer. Anticancer Res., 8, 711-716 (1988).
8. JEGO, N., THOMAS, G. and HAMELIN, R., Short direct repeats flanking deletions, and duplicating insertions in p53 gene in human cancers. Oncogene, 8, 209-213 (1993).
9. KAMB, A., GRUIS, N.A., WEAVER-FELDHAUS, J., LIU, Q., HARSHMAN, K., TAVTIGIAN, S.V., STOCKERT, E., DAY, R.S. III, JOHNSON, B.E. and SKOLNICK, M.H., A cell cycle regulator potentially involved in genesis of many tumor types. Science, 264, 436-440 (1994).
10. KOTZE, M.J., THEART, L., CALLIS, M., PEETERS, A.V., THIART, R. and LANGENHOVEN, E., Nonradioactive multiplex PCR screening strategy for the simultaneous detection of multiple low-density receptor gene mutations. PCR Methods Appl., 4, 352-356 (1995).
11. MARASAS, W.F.O., JASKIEWICZ, K., VENTER, F.S. and VAN SCHALKWYK, D.J., Fusarium moniliforme contamination of maize in esophageal cancer areas in Transkei. S.Afr. Med. J., 74, 110-114 (1988).
12. MONTESANO, R., HOLLSTEIN, M. and HAINAUT, P., Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review. Int. J. Cancer (Pred. Oncol.), 69, 225-235 (1996).
13. 1 cyclins. Cell, 73, 1059-1065 (1993).
14. SITAS, F., National Cancer Registry of South Africa. Annual Statistical Report for 1988, South African Institute for Medical Research, Johannesburg, South Africa (1992).
15. SKILLING, S.J., SOOD, A.K., NIEMANN, T., LAGER. D.J. and BULLER, R.E., An abundance of p53 null mutations in ovarian carcinoma. Oncogene, 13, 117-123 (1996).
16. STONE, S., JIANG, P., DAYANANTH, P., TAVTIGIAN, S.V., KATCHER, H., PARRY, D., PETERS, G. and KAMB, A., Complex structure and regulation of the p16 (MTS1) locus. Cancer Res., 55, 2988-2994 (1995).
17. SUN, Y., HILDESHEIM, A., LANIER, A.E.P., CAO, Y., YAO, K.-T., RAAB-TRAUB, N. and YANG, C.-S., No point mutations but decreased expression of p16/MTS1 tumor suppressor gene in naso-pharyngeal carcinomas. Oncogene, 10, 785-788 (1995).
18. TANAKA, H., SHIBAGAKI, I., SHIMADA, Y., WAGATA, T., IMAMURA, M. and TSHIZAKI, K., Characterization of p53 gene mutations in esophageal squamous cell carcinoma cell lines: increased frequency and different spectrum of mutations from primary tumors. Int. J. Cancer, 65, 372-376 (1996).
19. WANG, L.D., LIPKIN, M., QUI, S.L., YANG, G.R., YANG, C.S. and NEWMARK, H.L., Labeling index and labeling distribution of cells in esophageal epithelium of individuals at increased risk for esophageal cancer in Huixian, China. Cancer Res., 50, 2651-2653 (1990).
20. ZHANG, S.-Y., KLEIN-SZANTO, A.J.P., SAUTER, E.R., SHAFARENKO, M., MITSUNAGA, S., NOBIRI, T., CARSON, D.A., RIDGE, J.A. and GOODROW, T.L., Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. Cancer Res., 54, 5050-5053 (1994).
21. ZHOU, X., TARMIN, L., YIN, J., JIANG, H.-Y, SUZUKI, H., RHYU, M.G., ABRAHAM, J.A. and MELTZER, S.J., The MTS1 gene is frequently mutated in primary human esophageal tumors. Oncogene, 9, 3737-3741 (1994).